James Boylan ^Investor

James Boylan is an accomplished health care executive, entrepreneur, and innovator with nearly three decades of M&A transaction and capital markets experience. As the Chief Executive Officer at Enavate Sciences, he leads a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient needs. With a background in business management and a strong track record of success in the industry, James is focused on accelerating innovation and empowering a diverse portfolio of therapeutics companies. (63 words)